S2 E10 - Inhaled steroids for COVID in GP; risk of COVID in adults with kids; 3 days of antibiotics for pneumonia; more semaglutide stuff

NO PHARMACEUTICAL INFLUENCE
NO PHARMACEUTICAL INFLUENCE
26th March 2021

If you are having difficulties listening to this Podcast, try to play this episode in Spotify

Big news in this new Hot Topics podcast as we discuss very positive data on the role of inhaled budesonide for early mild COVID in community-based patients - the STOIC trial may radically change our management of COVID but why hasn't this been a huge story and should we wait to change our practice?

Also, we look at a BMJ paper examining the risk of catching and dying from COVID if you are an adult with children at home, a Lancet paper looking at only 3 days of antibiotics for pneumonia and more data on semaglutide and it's role in weight loss and improvement in non-alcoholic steatohepatitis.

References:

STOIC website and pre-print

BMJ COVID and kids cohort study

Lancet Pneumonia trial

Lancet Semaglutide and weight loss in T2DM

NEJM Semaglutide and NASH